Dai Lixin
| Company | Stock Code | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|---|
| Pharmaron | 03759 | 27-Oct-16 | 23-Sep-22 | INED | Due to the upcoming expiration of his six-year consecutive term of office as required according to the Rules for Independent Directors of Listed Companies of the China Securities Regulatory Commission | |
| Pharmaron,Pmr Bj B2606,Pmr Bj B2606b | 03759,40725,40733 | 23-Sep-22 | INED | No reasons provided. |